The Experts below are selected from a list of 147207 Experts worldwide ranked by ideXlab platform
Dennis Falzon - One of the best experts on this subject based on the ideXlab platform.
-
digital health technology for the end tb strategy developing priority products and making them work
European Respiratory Journal, 2016Co-Authors: Dennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, Mario RaviglioneAbstract:In 2014, the World Health Organization (WHO) elaborated the End TB Strategy in response to the World Health Assembly Resolution requesting Member States to work towards ending the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy9s objectives to be realised, novel solutions will be needed to address the challenges posed by TB to health professionals and to affected people and communities. Information and communication technology presents opportunities to innovate in support of TB care and prevention efforts. In late 2014, the European Respiratory Society and the Global TB Programme of WHO started a collaboration to promote the wider use of digital technology in TB care and prevention. In 2015 WHO established its “Global task force on digital health for TB” to help steward this process. By early 2016, target product profiles (TPPs) were developed by WHO and partners to define nine priority digital health concepts and products which are advantageously positioned to enhance patient care, surveillance, Programme Management and eLearning at country level. We discuss how the TPPs are being used to focus the input of end-users, innovators, funders, policy-makers and other stakeholders towards a common purpose and to create products which stay abreast of the state-of-the-art in technology, which can be effectively applied at large scale and which increase the knowledge on their potential impact.
-
digital health for the end tb strategy developing priority products and making them work
European Respiratory Journal, 2016Co-Authors: Dennis Falzon, Hazim Timimi, Pascal Kurosinski, Giovanni Battista Migliori, Wayne Van Gemert, Claudia M Denkinger, Chris Isaacs, Alistair Story, Richard S Garfein, Luis Gustavo Do Valle BastosAbstract:In 2014, the World Health Organization (WHO) developed the End TB Strategy in response to a World Health Assembly Resolution requesting Member States to end the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy's objectives to be realised, the next 20 years will need novel solutions to address the challenges posed by TB to health professionals, and to affected people and communities. Information and communication technology presents opportunities for innovative approaches to support TB efforts in patient care, surveillance, Programme Management and electronic learning. The effective application of digital health products at a large scale and their continued development need the engagement of TB patients and their caregivers, innovators, funders, policy-makers, advocacy groups, and affected communities.In April 2015, WHO established its Global Task Force on Digital Health for TB to advocate and support the development of digital health innovations in global efforts to improve TB care and prevention. We outline the group's approach to stewarding this process in alignment with the three pillars of the End TB Strategy. The supplementary material of this article includes target product profiles, as developed by early 2016, defining nine priority digital health concepts and products that are strategically positioned to enhance TB action at the country level.
Luis Gustavo Do Valle Bastos - One of the best experts on this subject based on the ideXlab platform.
-
digital health for the end tb strategy developing priority products and making them work
European Respiratory Journal, 2016Co-Authors: Dennis Falzon, Hazim Timimi, Pascal Kurosinski, Giovanni Battista Migliori, Wayne Van Gemert, Claudia M Denkinger, Chris Isaacs, Alistair Story, Richard S Garfein, Luis Gustavo Do Valle BastosAbstract:In 2014, the World Health Organization (WHO) developed the End TB Strategy in response to a World Health Assembly Resolution requesting Member States to end the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy's objectives to be realised, the next 20 years will need novel solutions to address the challenges posed by TB to health professionals, and to affected people and communities. Information and communication technology presents opportunities for innovative approaches to support TB efforts in patient care, surveillance, Programme Management and electronic learning. The effective application of digital health products at a large scale and their continued development need the engagement of TB patients and their caregivers, innovators, funders, policy-makers, advocacy groups, and affected communities.In April 2015, WHO established its Global Task Force on Digital Health for TB to advocate and support the development of digital health innovations in global efforts to improve TB care and prevention. We outline the group's approach to stewarding this process in alignment with the three pillars of the End TB Strategy. The supplementary material of this article includes target product profiles, as developed by early 2016, defining nine priority digital health concepts and products that are strategically positioned to enhance TB action at the country level.
Giovanni Battista Migliori - One of the best experts on this subject based on the ideXlab platform.
-
digital health technology for the end tb strategy developing priority products and making them work
European Respiratory Journal, 2016Co-Authors: Dennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, Mario RaviglioneAbstract:In 2014, the World Health Organization (WHO) elaborated the End TB Strategy in response to the World Health Assembly Resolution requesting Member States to work towards ending the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy9s objectives to be realised, novel solutions will be needed to address the challenges posed by TB to health professionals and to affected people and communities. Information and communication technology presents opportunities to innovate in support of TB care and prevention efforts. In late 2014, the European Respiratory Society and the Global TB Programme of WHO started a collaboration to promote the wider use of digital technology in TB care and prevention. In 2015 WHO established its “Global task force on digital health for TB” to help steward this process. By early 2016, target product profiles (TPPs) were developed by WHO and partners to define nine priority digital health concepts and products which are advantageously positioned to enhance patient care, surveillance, Programme Management and eLearning at country level. We discuss how the TPPs are being used to focus the input of end-users, innovators, funders, policy-makers and other stakeholders towards a common purpose and to create products which stay abreast of the state-of-the-art in technology, which can be effectively applied at large scale and which increase the knowledge on their potential impact.
-
digital health for the end tb strategy developing priority products and making them work
European Respiratory Journal, 2016Co-Authors: Dennis Falzon, Hazim Timimi, Pascal Kurosinski, Giovanni Battista Migliori, Wayne Van Gemert, Claudia M Denkinger, Chris Isaacs, Alistair Story, Richard S Garfein, Luis Gustavo Do Valle BastosAbstract:In 2014, the World Health Organization (WHO) developed the End TB Strategy in response to a World Health Assembly Resolution requesting Member States to end the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy's objectives to be realised, the next 20 years will need novel solutions to address the challenges posed by TB to health professionals, and to affected people and communities. Information and communication technology presents opportunities for innovative approaches to support TB efforts in patient care, surveillance, Programme Management and electronic learning. The effective application of digital health products at a large scale and their continued development need the engagement of TB patients and their caregivers, innovators, funders, policy-makers, advocacy groups, and affected communities.In April 2015, WHO established its Global Task Force on Digital Health for TB to advocate and support the development of digital health innovations in global efforts to improve TB care and prevention. We outline the group's approach to stewarding this process in alignment with the three pillars of the End TB Strategy. The supplementary material of this article includes target product profiles, as developed by early 2016, defining nine priority digital health concepts and products that are strategically positioned to enhance TB action at the country level.
Mario Raviglione - One of the best experts on this subject based on the ideXlab platform.
-
digital health technology for the end tb strategy developing priority products and making them work
European Respiratory Journal, 2016Co-Authors: Dennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, Mario RaviglioneAbstract:In 2014, the World Health Organization (WHO) elaborated the End TB Strategy in response to the World Health Assembly Resolution requesting Member States to work towards ending the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy9s objectives to be realised, novel solutions will be needed to address the challenges posed by TB to health professionals and to affected people and communities. Information and communication technology presents opportunities to innovate in support of TB care and prevention efforts. In late 2014, the European Respiratory Society and the Global TB Programme of WHO started a collaboration to promote the wider use of digital technology in TB care and prevention. In 2015 WHO established its “Global task force on digital health for TB” to help steward this process. By early 2016, target product profiles (TPPs) were developed by WHO and partners to define nine priority digital health concepts and products which are advantageously positioned to enhance patient care, surveillance, Programme Management and eLearning at country level. We discuss how the TPPs are being used to focus the input of end-users, innovators, funders, policy-makers and other stakeholders towards a common purpose and to create products which stay abreast of the state-of-the-art in technology, which can be effectively applied at large scale and which increase the knowledge on their potential impact.
Brendan Mcgrath - One of the best experts on this subject based on the ideXlab platform.
-
improving tracheostomy care in the united kingdom results of a guided quality improvement Programme in 20 diverse hospitals
BJA: British Journal of Anaesthesia, 2020Co-Authors: Brendan Mcgrath, Sarah E Wallace, James P Lynch, Barbara Bonvento, Barry Coe, Anna Owen, Mike Firn, Michael Brenner, Elizabeth A EdwardsAbstract:Abstract Background Inconsistent and poorly coordinated systems of tracheostomy care commonly result in frustrations, delays, and harm. Quality improvement strategies described by exemplar hospitals of the Global Tracheostomy Collaborative have potential to mitigate such problems. This 3 yr guided implementation Programme investigated interventions designed to improve the quality and safety of tracheostomy care. Methods The Programme Management team guided the implementation of 18 interventions over three phases (baseline/implementation/evaluation). Mixed-methods interviews, focus groups, and Hospital Anxiety and Depression Scale questionnaires defined outcome measures, with patient-level databases tracking and benchmarking process metrics. Appreciative inquiry, interviews, and Normalisation Measure Development questionnaires explored change barriers and enablers. Results All sites implemented at least 16/18 interventions, with the magnitude of some improvements linked to staff engagement (1536 questionnaires from 1019 staff), and 2405 admissions (1868 ICU/high-dependency unit; 7.3% children) were prospectively captured. Median stay was 50 hospital days, 23 ICU days, and 28 tracheostomy days. Incident severity score reduced significantly (n=606; P Conclusions This guided improvement Programme for tracheostomy patients significantly improved the quality and safety of care, contributing rich qualitative improvement data. Patient-centred outcomes were improved along with significant efficiency and cost savings across diverse UK hospitals. Clinical trial registration IRAS-ID-206955; REC-Ref-16/LO/1196; NIHR Portfolio CPMS ID 31544.